Navigate to
-
Reimagining pharmacy for our loved ones Please enter a valid video URL. The URL can point to any video file or a Youtube video. View playlist Please enter a valid video URL. The URL can point to...
-
Expert Clinical Insights Metastatic Melanoma MEDICATION INSIGHTS: Lifileucel (Amtagvi™) The U.S. Food and Drug Administration (FDA) approved lifileucel (Amtagvi™) in February 2024 through the...
-
Abby Kim, PharmD, BCOP, is a senior director, clinical strategy and oncology specialty solutions, shares key takeaways from the American Journal of Managed Care (AJMC) forum, “Bridging evidence and...
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
image from Healthcare Advocate Summit Prerak Parikh represented Prime on a panel at Healthcare Advocate Summit 2025 in Las Vegas on Sept. 4 with other payer/PBM professionals Prime Therapeutics At...
Prime Article: Stories -
Annual conference features presentations, panels, discussions and networking
Prime Article: Stories -
The American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection,...
PA Sub-Categories: Awards Prime Article: In the News -
AMCP 2026 spotlighted oncology innovation, AI, and payer strategies, with KOL insights on cost, access, and evolving managed care trends.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: In the News -
Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey
PA Sub-Categories: Corporate responsibility Prime Article: Stories -
cover image for MPTR blog Prime expert shares exciting enhancement to Medical Pharmacy Trend Report Lisa Polakowski Lisa Polakowski, PharmD, is the Medical Pharmacy Trend Report director for Prime...
Prime Article: Stories -
Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
AAVRh74var adeno-associated virus serotype Rh74var ABSSSI acute bacterial skin and skin structure infections AChR acetylcholine receptor ADHD attention deficit hyperactivity disorder ALK anaplastic...
-
New indications for approved traditional drugs - 2025 Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* zopapogene imadenovec-drba Papzimeos Precigen...
-
New indications for approved traditional drugs - 2025 Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* mitomycin intravesical solution Zusduri Urogen...
-
Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* cosibelimab-ipdl Unloxcyt Checkpoint Metastatic or locally advanced cutaneous squamous cell carcinoma IV...
-
Jan-Apr 2025 (last posted March 24, 2026): — NADAC Public Report Document #1 — NADAC Public Report Document #2 May-Aug 2025 (last posted January 16, 2026): — NADAC Public Report Document #1 — NADAC...
-
Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* diazoxide choline Vykat XR Soleno Hyperphagia in Prader-Willi syndrome (≥ 4 years of age) Oral March...
-
publications Quarterly Drug Approvals: October 2024 This report provides an overview of new drugs and indications approved in 2024 Generic Name Brand Name Manufacturer Indication(s) Month Approved*...
-
Learn how Prime champions cancer care through its industry-leading solutions, clinical insights, charitable giving and volunteer efforts
PA Sub-Categories: Corporate responsibility Products Prime Article: Stories -
Configure the table properties Cellular and gene therapy and biosimilar approvals Oncology drug approvals - 2026 None Configure the table properties Specialty drug approvals Traditional drug...
-
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax....
-
9 Comprehensive outcomes reporting Insert Link Learn more about cystic fibrosis We support members navigating their cystic fibrosis (CF) with a holistic, customized approach to care. Tab 1 Holistic...
-
$3,413 Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing strategies, for all lines of business. When...
-
Connect care for your members with cancer Home Our solutions Specialty drug management IntegratedRx IntegratedRx - Oncology Reducing the risk of major side effects IntegratedRx® streamlines the...
-
Insert Link Explore Medical Pharmacy Solutions Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing...
-
IntegratedRx – Cystic Fibrosis drives $28,200 in savings annually per utilizing member.¹ Provider has minimal connection to central specialty pharmacy. Footnotes 1 Based on actual claims,...
-
Discover our value-based contracting solution Support your members with hemophilia We deliver the insights you need on member adherence, program performance and much more with our robust reporting...
-
April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth leading cause of cancer related death.¹ In 2023, approximately 64,050 people were...
-
Concerns about pricing remain prominent, reflecting the continued introduction of high‑cost agents and the expansion of existing therapies into earlier lines of treatment and longer durations of...
-
IntegratedRx®– Cystic Fibrosis streamlines the cystic fibrosis treatment pathway with in-house dispensing and a coordinated care team. Oncology Integration is key Connected physician, member and...
-
Nondiscrimination & Languages Prime Therapeutics (Prime) complies with applicable federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability...
-
Tab 1 Holistic support across medical & pharmacy benefit Pharmacy benefit Medical benefit Footnotes 72% Multiple sclerosis is a potentially disabling disease of the brain and spinal cord (central...
-
NCCN Recommendations for use of immunoglobulin² Intervention CAR T BsAbs Other indications Immunoglobulin replacement After CAR T-cell therapy, regular immune globulin infusions based on clinical...
-
GuidedHealth can help you save up to $2 per member per month (PMPM).1 1 Prime internal data, 2024; savings specific to health plan, not employer group Home Our solutions Clinical solutions...
-
Heading Example A paragraph is a self-contained unit of a discourse in writing dealing with a particular point or idea. Paragraphs are usually an expected part of formal writing, used to organize...
-
State homepage CMS approval letter Alaska Minnesota State homepage CMS approval letter Michigan State homepage CMS approval letter New Hampshire Attachment B – Catalogue of NMPI participating...
-
Prime Therapeutics Pharmacy LLC Expires 06/03/2027 Prime Therapeutics Management LLC Expires 08/01/2026 View accreditation Prime Therapeutics Pharmacy LLC Expires 04/18/2028 Tab 1 For your patients...
-
$1 MILLION Contact us to learn more The state estimates they will treat 10 patients with Product X over the next 12 months for a total spend of $10 million. Tie costs to outcomes with VBCs 7,000...
-
Expert Clinical Insights A look into our Expert Clinical Network (ECN) — part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that offers access to more than 175...
-
Over time, technology has significantly contributed to health care advancements. Some of these enhancements are now considered routine components of care and include electronic health record,...